Physician profile
Sunhee Park
NPI 1225305915
$89,594.83
in general payments reported to CMS, 2019-2025
16 companies · $12K in 2025
The $12K reported for 2025 was more than what 93% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,070 · 2020: $3,375 · 2021: $8,449 · 2022: $16K · 2023: $16K · 2024: $28K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $47K · Travel and Lodging: $4,608 · Consulting Fee: $4,195 · Food and Beverage: $1,599 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $46,668.75 |
| Travel and Lodging | $4,608.47 |
| Consulting Fee | $4,195.00 |
| Food and Beverage | $1,599.38 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $42,200.40 | 2020-2025 | |
| Lilly USA, LLC | $27,570.99 | 2023-2025 | Omvoh |
| Pfizer INC. | $4,960.92 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $3,968.99 | 2022 | |
| Nestle Healthcare Nutrition INC. | $3,734.83 | 2022-2023 | |
| Celltrion USA INC. | $2,727.33 | 2024 | Zymfentra |
| Janssen Scientific Affairs, LLC | $1,960.72 | 2019-2024 | Tremfya |
| Medtronic, INC. | $970.13 | 2024-2025 | Endoflip |
| Celgene Corporation | $721.49 | 2022 | |
| Cook Medical LLC | $544.22 | 2022-2023 | Echotip |
| Phathom Pharmaceuticals, INC. | $123.86 | 2024 | Voquezna |
| Janssen Biotech, INC. | $84.99 | 2024 | Stelara |
| Chiesi USA, INC. | $25.96 | 2021 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunhee Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.